Immunomodulators is an immunomodulator composed of heat-killed Mycobacterium W (Mw), indicated to treat NSCLC (Non-small Cell Lung Cancer) and other anticancer agents leading to improvement in overall response, quality of life, and survival of patients. It contains the active ingredient Mitomycin C, a type of chemotherapy drug. It can be used with other chemotherapy drugs or as a standalone treatment. Patients should avoid live vaccines while receiving Immunomodulators or several months after completing the treatment as the immune system may weaken. This medication can increase the risk of radiation-induced toxicity when combined with radiation therapy. Dose adjustments or close monitoring may be required in such patients.

Immunomodulator is an immunomodulatory agent used as adjuvant therapy in treating various types of cancer, including gastric, colorectal, and breast cancer.

Immunomodulator is a medication administered intravenously (IV) by a healthcare professional. It is important to follow the healthcare provider's instructions regarding the dosage and administration of medication. Refrain from doubling the dose to make up for missed doses.

Immunomodulator can cause several side effects, both common and serious. Common side effects may include pain, swelling, redness at the injection site, fever, headache, fatigue, nausea, vomiting, and diarrhea. Serious side effects may include anaphylactic shock, severe hypersensitivity reactions, and pulmonary embolism.

It is important to be aware of the warnings associated with immunomodulators. This medication can cause severe hypersensitivity reactions or anaphylactic shock in patients who are allergic to it. It is also not recommended for use in patients with autoimmune disorders or those who are immunocompromised. Other warnings include the potential for cardiac events, liver and kidney damage, and pulmonary embolism.

Patients with a history of severe hypersensitivity reactions or anaphylactic shock should not receive Immunomodulators. It is also not recommended for use in patients with autoimmune disorders or those who are immunocompromised. Patients with a history of cardiac events, liver or kidney disease, or pulmonary embolism should be closely monitored during Immunomodulators.

If you are prescribed Immunomodulators or any other medication, it is important to carefully read and understand the warnings and precautions associated with the medication. Patients should be monitored for signs of an allergic reaction, such as rash, itching, or swelling, and should seek immediate medical attention if these symptoms occur. It should be used with caution in patients with severe renal impairment. Pregnant and breastfeeding women should discuss potential risk and benefit with a healthcare provider before taking this medication. Always maintain a healthy and balanced diet to support your overall health and well-being.

1. Cadila Pharmaceuticals, [Revised on 2021] [Accessed on 12th Aug 2021],  https://www.cadilapharma.com/research/worlds-first-innovation/
2. Krunal Kavathiya., et al. “Desmocollin-3 and Cancer”. Acta Scientific Cancer Biology 3.9 (2019): 19-28, https://www.actascientific.com/ASCB/pdf/ASCB-03-0155.pdf
3. Cancer Immunotherapy: Immune Suppression and Tumor Growth, Fourth edition, 2007, 507-536

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.